SDC2 and cancer: Consistently, Niu and colleagues detected in tissue specimens a very high frequency of SDC2 promoter hypermethylation in 83% of the CRC tumors (103/124) and further demonstrated that methylation level was higher in 96.8% (120/124) of cancers than in their paired adjacent normal epithelia [27].